中駿集團控股(01966.HK):控股股東黃朝陽再增持750萬股 持股升至50.22%
格隆匯11月3日丨中駿集團控股(01966.HK)宣佈,董事會獲新昇(一間於英屬處女羣島註冊成立及由公司執行董事、主席及控股股東黃朝陽全資持有的公司)吿知,新昇已於2021年10月29日-11月2日期間於市場上以每股平均購買價2.41358港元增持總數750萬股公司每股面值0.10港元的普通股。
緊隨上述新昇增持股份後,黃朝陽根據香港法例第571章證券及期貨條例第XV部擁有權益的股份數目由21.13億股股份增加至21.205億股股份,即相當於公司現有已發行股份的約50.22%。
根據公司所得資料及據董事會所知,緊隨上述增持後及於該公吿日期,公司仍保持充足公眾持股量。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.